BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aichholzer F, Klafki HW, Ogorek I, Vogelgsang J, Wiltfang J, Scherbaum N, Weggen S, Wirths O. Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease. Alzheimers Res Ther 2021;13:94. [PMID: 33947460 DOI: 10.1186/s13195-021-00828-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Mollenhauer B, von Arnim CAF. Toward preventing Parkinson's disease. Science 2022;377:818-9. [PMID: 35981039 DOI: 10.1126/science.add7162] [Reference Citation Analysis]
2 Taghizadeh LA, King CJ, Nascene DR, Gupta AO, Orchard PJ, Higgins L, Markowski TW, Nolan EE, Furcich JW, Lund TC. Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy. Sci Rep 2022;12:7985. [PMID: 35568699 DOI: 10.1038/s41598-022-11552-7] [Reference Citation Analysis]
3 Vastrad B, Vastrad C. Bioinformatics and next generation sequencing data analysis to identify key genes and pathways influencing in Parkinson’s disease.. [DOI: 10.1101/2022.02.27.482208] [Reference Citation Analysis]
4 Klafki HW, Wirths O, Mollenhauer B, Liepold T, Rieper P, Esselmann H, Vogelgsang J, Wiltfang J, Jahn O. Detection and quantification of Aβ-3-40 (APP669-711) in cerebrospinal fluid. J Neurochem 2022. [PMID: 34984682 DOI: 10.1111/jnc.15571] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Doke M, Ramasamy T, Sundar V, McLaughlin JP, Samikkannu T. Proteomics Profiling with SWATH-MS Quantitative Analysis of Changes in the Human Brain with HIV Infection Reveals a Differential Impact on the Frontal and Temporal Lobes. Brain Sci 2021;11:1438. [PMID: 34827437 DOI: 10.3390/brainsci11111438] [Reference Citation Analysis]